Key Insights

Highlights

Success Rate

79% trial completion

Published Results

24 trials with published results (19%)

Research Maturity

60 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

12.9%

16 terminated out of 124 trials

Success Rate

78.9%

-7.6% vs benchmark

Late-Stage Pipeline

10%

12 trials in Phase 3/4

Results Transparency

40%

24 of 60 completed with results

Key Signals

24 with results79% success16 terminated

Data Visualizations

Phase Distribution

87Total
Not Applicable (54)
Early P 1 (2)
P 1 (6)
P 2 (13)
P 3 (9)
P 4 (3)

Trial Status

Completed60
Recruiting19
Terminated16
Unknown10
Withdrawn5
Active Not Recruiting5

Trial Success Rate

78.9%

Benchmark: 86.5%

Based on 60 completed trials

Clinical Trials (124)

Showing 20 of 20 trials
NCT07227909Phase 2Not Yet Recruiting

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

NCT04917796Not ApplicableActive Not Recruiting

The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)

NCT02795052Not ApplicableRecruiting

Neurologic Stem Cell Treatment Study

NCT05469321TerminatedPrimary

Neurological Impairment in a Young Population Exposed to Recreational Nitrous Oxide

NCT07635901Not ApplicableCompletedPrimary

Exercise Intervention for Chemotherapy-Induced Peripheral Neuropathy

NCT01451853Phase 2Withdrawn

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

NCT07390617RecruitingPrimary

A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

NCT04207437Not ApplicableRecruitingPrimary

Daily Hand-Held Vibration Therapy

NCT03881930Not ApplicableRecruitingPrimary

Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy

NCT06443281Recruiting

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

NCT05691738Not ApplicableCompleted

Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy

NCT04650178Active Not Recruiting

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

NCT07095998Not ApplicableRecruiting

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

NCT01864460Not ApplicableCompleted

Improving Autonomic Function and Balance in Diabetic Neuropathy

NCT02610439Recruiting

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

NCT05041387RecruitingPrimary

Data Collection of Standard Care of Patients in the EMG Section

NCT07137078Not ApplicableCompletedPrimary

Pilates Versus Gyrotonic Expansion System on Chemotherapy Induced Peripheral Neuropathy and Fall Risk

NCT07437989RecruitingPrimary

Collection of Demographic, Clinical, and Instrumental Data of Patients With Peripheral Neuropathy Including Neurological Examination Data, Peripheral Nerve Conduction Analysis, and Nerve Electromyography and Ultrasound).

NCT06837181Recruiting

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

NCT05121558Not ApplicableActive Not Recruiting

The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)

Scroll to load more

Research Network

Activity Timeline